Santiago - Delayed Quote USD
Abbott Laboratories (ABT.SN)
135.90
+23.49
+(20.90%)
At close: February 24 at 12:07:06 PM GMT-3
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 21 | 21 | 26 | 26 |
Avg. Estimate | 11.01B | 11.36B | 44.63B | 48.02B |
Low Estimate | 10.38B | 10.63B | 44.1B | 47.05B |
High Estimate | 11.13B | 11.62B | 45.1B | 49.07B |
Year Ago Sales | 10.38B | 10.63B | 41.95B | 44.63B |
Sales Growth (year/est) | 6.09% | 6.79% | 6.39% | 7.60% |
EPS Trend
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
ABT.SN | -- | -- | -- | -- |
S&P 500 | 13.13% | 2.43% | 7.54% | 14.06% |
Upgrades & Downgrades
Maintains | Raymond James: Outperform to Outperform | 4/17/2025 |
Reiterates | Piper Sandler: Overweight to Overweight | 4/17/2025 |
Maintains | RBC Capital: Outperform to Outperform | 4/17/2025 |
Maintains | Wells Fargo: Overweight to Overweight | 4/17/2025 |
Maintains | Morgan Stanley: Equal-Weight to Equal-Weight | 4/17/2025 |
Maintains | Barclays: Overweight to Overweight | 4/17/2025 |